Lucentia develops artificial-intelligence technology that turns routine cardiac CT scans into coronary diagnostics, including a virtual CCTA generated from a non-contrast CAC scan. Its platform is built on five years of NIH-funded cardiac imaging research at Weill Cornell Medicine and is designed to provide high-fidelity cardiac insights without relying on contrast agents or specialized imaging workflows.
Riverain TechnologiesFor more than 20 years, Riverain Technologies has developed AI software that helps clinicians interpret chest CT and X-ray images, with its ClearRead suite focused on earlier detection of cardiothoracic disease. Based in Miamisburg, Ohio, the company was an early force in AI-driven medical imaging, earning the first FDA approval for chest X-ray computer-aided detection and developing patented suppression technology that gives radiologists a clearer view of the chest. ClearRead is deployed at more than 400 customer locations worldwide and integrates with existing PACS workflows.MIAMISBURG, OH
Positron CorporationWith nearly 40 years devoted to cardiac PET, Positron Corporation co-develops, manufactures and sells PET and PET-CT imaging systems for nuclear medicine providers across North America. Based in Buffalo, the company pairs its Attrius PET and NeuSight 64-slice PET-CT platforms with clinical, technical and training support, helping practices adopt molecular imaging for cardiac diagnostics while also serving oncology and neurology applications. Its compact dedicated cardiac PET system and integrated service model distinguish Positron in a field where equipment and operational support must work together.NIAGARA FALLS, NY
Powerful MedicalFounded in 2020 by a team that includes brothers Martin and Dr. Robert Herman, Powerful Medical develops certified AI software for cardiovascular diagnosis, centered on its PMcardio platform for rapid 12-lead ECG interpretation. Its Queen of Hearts model is designed to detect occlusive heart attacks that standard STEMI criteria can miss, while PMcardio for Organizations connects those findings to hospital and emergency-care workflows. The Bratislava-based company says its platform has analyzed more than 2.5 million ECGs and is used by over 100,000 clinicians across 150-plus hospital deployments.NEW YORK, NY
Accumetra, LLCFounded by imaging scientist Ricardo Avila, Accumetra develops medical imaging phantoms and cloud-based software for CT lung-cancer screening and quantitative image-quality assurance. Based in Clifton Park, the company draws on more than 25 years of lung-screening technology experience to help clinical sites verify scanner performance and manage screening programs.CLIFTON PARK, NY